Tet2 restrains inflammatory gene expression in macrophages
Open accessAbstract
Tet methylcytosine dioxygenase 2 (TET2) is one of the earliest and most frequently mutated genes in clonal hematopoiesis of indeterminate potential (CHIP) and myeloid cancers, including myelodysplastic syndromes (MDS) and chronic myelomonocytic leukemia (CMML). TET2 catalyzes the oxidation of 5-methylcytosine to 5-hydroxymethylcytosine, leading to DNA demethylation, and also affects transcription by recruiting histone modifiers. Inactivating TET2 mutations cause epigenetic dysregulation, clonal hematopoietic stem cell (HSC) dominance, and monocytic lineage skewing. Here, we found that Tet2 was the most highly expressed Tet enzyme in murine macrophage (MΦ) differentiation. Tet2 transcription was further induced by lipopolysaccharide (LPS), but not interleukin (IL)-4, stimulation, potentially in a nuclear factor κβ-dependent manner. Tet2 loss did not affect early LPS gene responses in vitro, but increased Il-1b, Il-6, and Arginase 1 (Arg1) mRNA expression at later stages of stimulation in bone-marrow-derived MΦs (BMMΦs). Tet2-deficient peritoneal MΦs, however, demonstrated profound, constitutive expression of LPS-induced genes associated with an inflammatory state in vivo. In contrast, Tet2 deficiency did not affect alternative MΦ gene expression significantly in response to IL-4. These results suggested impaired resolution of inflammation in the absence of Tet2 both in vitro and in vivo. For the first time, we also detected TET2 mutations in BMMΦs from MDS and CMML patients and assayed their effects on LPS responses, including their potential influence on human IL-6 expression. Our results show that Tet2 restrains inflammation in murine MΦs and mice, raising the possibility that loss of TET2 function in MΦs may alter the immune environment in the large elderly population with TET2-mutant CHIP and in TET2-mutant myeloid cancer patients.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
A role for TET2 during the resolution of inflammation has also been described in bone-derived macrophages.
“A role for TET2 during the resolution of inflammation has also been described in bone-derived macrophages (Cull et al., 2017).”
From TET2 Regulates the Neuroinflammatory Response in Microglia (2019) · cites this paper as Cull et al., 2017
Many CH-associated mutations themselves contribute to increased inflammatory signaling, including mutations in TET2, FLT3, JAK2, STAT1, CBL, and RAS.
“Since many CH-associated mutations themselves contribute to increased inflammatory signaling, including mutations in TET2, FLT3, JAK2, STAT1, CBL, and RAS (Azrakhsh et al., 2019; Cull et al., 2017; Jaiswal et al., 2017)”
From Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling (2021) · cites this paper as Cull et al., 2017
In the context of CHIP, Tet2 loss-of-function mutations in myeloid cells result in increased proinflammatory responses, with reported increases in both IL-1 and IL-6 production.
“in the context of CHIP, Tet2 loss-of-function mutations in myeloid cells result in increased proinflammatory responses, with reported increases in both IL-124,43 and IL-6 production,27”
From Aging drives <i>Tet2</i> <i>+/−</i> clonal hematopoiesis via IL-1 signaling (2023) · cites this paper as [43]
Il1b, IL8 family chemokines, and other inflammatory mediators show increased expression in Tet2-deficient macrophages challenged with low-density lipoprotein or endotoxin.
“also found that Il1b, IL8 family chemokines, and other inflammatory mediators show increased expression in Tet2-deficient macrophages challenged with low-density lipoprotein or endotoxin 79,86,92”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [92]
Subsequent studies have confirmed over-expression of Il6 in Tet2-deficient macrophages challenged with low-density lipoprotein or endotoxin.
“Subsequent studies have confirmed the over-expression of Il6”
From Clonal hematopoiesis in human aging and disease (2019) · cites this paper as [92]
Cites
Macrophage activation and polarization: nomenclature and experimental guidelines
Murray, P. J., Allen, J. E., Biswas, S. K., Fisher, E. A., Gilroy, D. W., Goerdt, S., Gordon, S., Hamilton, J. A., Ivashkiv, L. B., Lawrence, T., et al. (2014) · Immunity · doi:10.1016/j.immuni.2014.06.008 · Cited by 6,337 · see citing works
Age-related clonal hematopoiesis associated with adverse outcomes
Jaiswal, S., Fontanillas, P., Flannick, J., Manning, A., Grauman, P. V., Mar, B. G., Lindsley, R. C., Mermel, C. H., Burtt, N., Chavez, A., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1408617 · Cited by 4,841 · see citing works
Clonal hematopoiesis and risk of atherosclerotic cardiovascular disease
Jaiswal, S., Natarajan, P., Silver, A. J., Gibson, C. J., Bick, A. G., Shvartz, E., McConkey, M., Gupta, N., Gabriel, S., Ardissino, D., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1701719 · Cited by 2,683 · see citing works
The Immunological Genome Project: networks of gene expression in immune cells
The Immunological Genome Project Consortium, Heng, T. S. P., Painter, M. W., Elpek, K., Lukacs-Kornek, V., Mauermann, N., Turley, S. J., Koller, D., Kim, F. S., Wagers, A. J., et al. (2008) · Nature Immunology · doi:10.1038/ni1008-1091 · Cited by 1,864 · see citing works
Clinical and biological implications of driver mutations in myelodysplastic syndromes
Papaemmanuil, E., Gerstung, M., Malcovati, L., Tauro, S., Gundem, G., Van Loo, P., Yoon, C. J., Ellis, P., Wedge, D. C., Pellagatti, A., et al. (2013) · Blood · doi:10.1182/blood-2013-08-518886 · Cited by 1,832 · see citing works
Mutation in <i>TET2</i> in Myeloid Cancers
Delhommeau, F., Dupont, S., Valle, V. D., James, C., Trannoy, S., Massé, A., Kosmider, O., Le Couedic, J.-P., Robert, F., Alberdi, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810069 · Cited by 1,776 · see citing works
Clonal hematopoiesis associated with TET2 deficiency accelerates atherosclerosis development in mice
Fuster, J. J., MacLauchlan, S., Zuriaga, M. A., Polackal, M. N., Ostriker, A. C., Chakraborty, R., Wu, C.-L., Sano, S., Muralidharan, S., Rius, C., et al. (2017) · Science · doi:10.1126/science.aag1381 · Cited by 1,536 · see citing works
Landscape of genetic lesions in 944 patients with myelodysplastic syndromes
Haferlach, T., Nagata, Y., Grossmann, V, Okuno, Y., Bacher, U., Nagae, G., Schnittger, S., Sanada, M., Kon, A., Alpermann, T., et al. (2014) · Leukemia · doi:10.1038/leu.2013.336 · Cited by 1,532 · see citing works
Gene-specific control of inflammation by TLR-induced chromatin modifications
Foster, S. L., Hargreaves, D. C., & Medzhitov, R. (2007) · Nature · doi:10.1038/nature05836 · Cited by 1,344 · see citing works
Tet2 loss leads to increased hematopoietic stem cell self-renewal and myeloid transformation
Moran-Crusio, K., Reavie, L., Shih, A., Abdel-Wahab, O., Ndiaye-Lobry, D., Lobry, C., Figueroa, M. E., Vasanthakumar, A., Patel, J., Zhao, X., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.001 · Cited by 1,339 · see citing works
Fine-Tuning Some Resistant Rules for Outlier Labeling
Hoaglin, D. C., & Iglewicz, B. (1987) · Journal of the American Statistical Association · doi:10.1080/01621459.1987.10478551 · Cited by 1,211 · see citing works
Mesenchymal stem cells use extracellular vesicles to outsource mitophagy and shuttle microRNAs
Phinney, D. G., Di Giuseppe, M., Njah, J., Sala, E., Shiva, S., St Croix, C. M., Stolz, D. B., Watkins, S. C., Di, Y. P., Leikauf, G. D., et al. (2015) · Nature Communications · doi:10.1038/ncomms9472 · Cited by 1,007 · see citing works
Quivoron, C., Couronné, L., Della Valle, V., Lopez, C. K., Plo, I., Wagner-Ballon, O., Do Cruzeiro, M., Delhommeau, F., Arnulf, B., Stern, M.-H., et al. (2011) · Cancer Cell · doi:10.1016/j.ccr.2011.06.003 · Cited by 924 · see citing works
Tet2 is required to resolve inflammation by recruiting Hdac2 to specifically repress IL-6
Zhang, Q., Zhao, K., Shen, Q., Han, Y., Gu, Y., Li, X., Zhao, D., Liu, Y., Wang, C., Zhang, X., et al. (2015) · Nature · doi:10.1038/nature15252 · Cited by 807 · see citing works
IL-6 induces an anti-inflammatory response in the absence of SOCS3 in macrophages
Yasukawa, H., Ohishi, M., Mori, H., Murakami, M., Chinen, T., Aki, D., Hanada, T., Takeda, K., Akira, S., Hoshijima, M., et al. (2003) · Nature Immunology · doi:10.1038/ni938 · Cited by 771 · see citing works
Acquired mutations in TET2 are common in myelodysplastic syndromes
Langemeijer, S. M. C., Kuiper, R. P., Berends, M., Knops, R., Aslanyan, M. G., Massop, M., Stevens-Linders, E., van Hoogen, P., van Kessel, A. G., Raymakers, R. A. P., et al. (2009) · Nature Genetics · doi:10.1038/ng.391 · Cited by 755 · see citing works
Li, Z., Cai, X., Cai, C.-L., Wang, J., Zhang, W., Petersen, B. E., Yang, F.-C., & Xu, M. (2011) · Blood · doi:10.1182/blood-2010-12-325241 · Cited by 671 · see citing works
El Kasmi, K. C., Qualls, J. E., Pesce, J. T., Smith, A. M., Thompson, R. W., Henao-Tamayo, M., Basaraba, R. J., König, T., Schleicher, U., Koo, M.-S., et al. (2008) · Nature Immunology · doi:10.1038/ni.1671 · Cited by 646 · see citing works
Ko, M., Bandukwala, H. S., An, J., Lamperti, E. D., Thompson, E. C., Hastie, R., Tsangaratou, A., Rajewsky, K., Koralov, S. B., & Rao, A. (2011) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1112317108 · Cited by 616 · see citing works
Prognostic Score Including Gene Mutations in Chronic Myelomonocytic Leukemia
Itzykson, R., Kosmider, O., Renneville, A., Gelsi‐Boyer, V., Meggendorfer, M., Morabito, M., Berthon, C., Adès, L., Fenaux, P., Beyne‐Rauzy, O., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.47.3314 · Cited by 546 · see citing works
SOCS3 Deficiency Promotes M1 Macrophage Polarization and Inflammation
Qin, H., Holdbrooks, A. T., Liu, Y., Reynolds, S. L., Yanagisawa, L. L., & Benveniste, E. N. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1201168 · Cited by 454 · see citing works
The NLRP3 inflammasome functions as a driver of the myelodysplastic syndrome phenotype
Basiorka, A. A., McGraw, K. L., Eksioglu, E. A., Chen, X., Johnson, J., Zhang, L., Zhang, Q., Irvine, B. A., Cluzeau, T., Sallman, D. A., et al. (2016) · Blood · doi:10.1182/blood-2016-07-730556 · Cited by 356 · see citing works
Zambetti, N. A., Ping, Z., Chen, S., Kenswil, K. J. G., Mylona, M. A., Sanders, M. A., Hoogenboezem, R. M., Bindels, E. M. J., Adisty, M. N., Van Strien, P. M. H., et al. (2016) · Cell stem cell · doi:10.1016/j.stem.2016.08.021 · Cited by 342 · see citing works
Bagger, F. O., Sasivarevic, D., Sohi, S. H., Laursen, L. G., Pundhir, S., Sønderby, C. K., Winther, O., Rapin, N., & Porse, B. T. (2015) · Nucleic Acids Research · doi:10.1093/nar/gkv1101 · Cited by 330 · see citing works
Ichiyama, K., Chen, T., Wang, X., Yan, X., Kim, B.-S., Tanaka, S., Ndiaye-Lobry, D., Deng, Y., Zou, Y., Zheng, P., et al. (2015) · Immunity · doi:10.1016/j.immuni.2015.03.005 · Cited by 327 · see citing works
Kohlmann, A., Großmann, V., Klein, H., Schindela, S., Weiss, T., Kazak, B., Dicker, F., Schnittger, S., Dugas, M., Kern, W., et al. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.1361 · Cited by 300 · see citing works
SHIP Represses the Generation of Alternatively Activated Macrophages
Rauh, M. J., Ho, V. W., Pereira, C. C., Sham, A. P., Sly, L. M., Lam, V., Huxham, L. A., Minchinton, A. I., Mui, A., & Krystal, G. (2005) · Immunity · doi:10.1016/j.immuni.2005.09.003 · Cited by 298 · see citing works
Clonal diversity of recurrently mutated genes in myelodysplastic syndromes
Walter, M. J., Shen, D., Shao, J., Ding, L., White, B. S., Kandoth, C., Miller, C. A., Niu, B., McLellan, M. D., Dees, N. D., et al. (2013) · Leukemia · doi:10.1038/leu.2013.58 · Cited by 284 · see citing works
Hematopoietic stem cell and progenitor cell mechanisms in myelodysplastic syndromes
Pang, W. W., Pluvinage, J. V., Price, E. A., Sridhar, K., Arber, D. A., Greenberg, P. L., Schrier, S. L., Park, C. Y., & Weissman, I. L. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222861110 · Cited by 277 · see citing works
Chen, W., Han, C., Xie, B., Hu, X., Yu, Q., Shi, L., Wang, Q., Li, D., Wang, J., Zheng, P., et al. (2013) · Cell · doi:10.1016/j.cell.2013.01.011 · Cited by 274 · see citing works
Rasmussen, K. D., Jia, G., Johansen, J. V., Pedersen, M. T., Rapin, N., Bagger, F. O., Porse, B. T., Bernard, O. A., Christensen, J., & Helin, K. (2015) · Genes & Development · doi:10.1101/gad.260174.115 · Cited by 270 · see citing works
Tefferi, A., Lim, K.-H., Abdel-Wahab, O. I., Lasho, T. L., Patel, J. L., Patnaik, M. M., Hanson, C., Pardanani, A. D., Gilliland, D. G., & Levine, R. L. (2009) · Leukemia · doi:10.1038/leu.2009.59 · Cited by 268 · see citing works
Kitagawa, M., Saito, I., Kuwata, T., Yoshida, S., Yamaguchi, S., Takahashi, M., Tanizawa, T., Kamiyama, R., & Hirokawa, K. (1997) · Leukemia · doi:10.1038/sj.leu.2400844 · Cited by 254 · see citing works
Generation and Characterization of Murine Alternatively Activated Macrophages
Weisser, S. B., McLarren, K. W., Kuroda, E., & Sly, L. M. (2012) · Methods in molecular biology · doi:10.1007/978-1-62703-128-8_14 · Cited by 239 · see citing works
Sekeres, M. A., Othus, M., List, A. F., Odenike, O., Stone, R. M., Gore, S. D., Litzow, M. R., Buckstein, R., Fang, M., Roulston, D., et al. (2017) · Journal of Clinical Oncology · doi:10.1200/jco.2015.66.2510 · Cited by 237 · see citing works
Deregulation of innate immune and inflammatory signaling in myelodysplastic syndromes
Gañán-Gómez, I., Wei, Y., Starczynowski, D. T., Colla, S., Yang, H., Cabrero-Calvo, M., Bohannan, Z. S., Verma, A., Steidl, U., & Garcia-Manero, G. (2015) · Leukemia · doi:10.1038/leu.2015.69 · Cited by 236 · see citing works
Epigenetic targets in hematopoietic malignancies
Claus, R., & Lübbert, M. (2003) · Oncogene · doi:10.1038/sj.onc.1206814 · Cited by 214 · see citing works
de la Rica, L., Rodríguez-Ubreva, J., García, M., Islam, A. B., Urquiza, J. M., Hernando, H., Christensen, J., Helin, K., Gómez-Vaquero, C., & Ballestar, E. (2013) · Genome Biology · doi:10.1186/gb-2013-14-9-r99 · Cited by 211 · see citing works
Acute loss of TET function results in aggressive myeloid cancer in mice
An, J., González‐Avalos, E., Chawla, A., Jeong, M., López-Moyado, I. F., Li, W., Goodell, M. A., Chávez, L., Ko, M., & Rao, A. (2015) · Nature Communications · doi:10.1038/ncomms10071 · Cited by 204 · see citing works
TET proteins and 5‐methylcytosine oxidation in hematological cancers
Ko, M., An, J., Pastor, W. A., Koralov, S. B., Rajewsky, K., & Rao, A. (2014) · Immunological Reviews · doi:10.1111/imr.12239 · Cited by 197 · see citing works
Chang, H. Y., Lee, H., Kim, W., & Surh, Y. (2014) · Life Sciences · doi:10.1016/j.lfs.2014.10.014 · Cited by 153 · see citing works
Stephens, A. S., Stephens, S., & Morrison, N. A. (2011) · BMC Research Notes · doi:10.1186/1756-0500-4-410 · Cited by 149 · see citing works
Großmann, V., Kohlmann, A., Eder, C., Haferlach, C., Kern, W., Cross, N. C. P., Haferlach, T., & Schnittger, S. (2011) · Leukemia · doi:10.1038/leu.2011.10 · Cited by 143 · see citing works
Epigenetic Changes in Solid and Hematopoietic Tumors
Toyota, M., & Issa, J. J. (2005) · Seminars in Oncology · doi:10.1053/j.seminoncol.2005.07.003 · Cited by 133 · see citing works
Figueroa, E. F., Gutiérrez-Espíndola, G. R., Montesinos, J. J., Arana-Trejo, R. M., & Mayani, H. (2002) · Leukemia Research · doi:10.1016/s0145-2126(01)00193-x · Cited by 127 · see citing works
Epigenetic Changes in the Myelodysplastic Syndrome
Issa, J. J. (2010) · Hematology/Oncology Clinics of North America · doi:10.1016/j.hoc.2010.02.007 · Cited by 106 · see citing works
IFNα enhances the production of IL-6 by human neutrophils activated via TLR8
Zimmermann, M., Arruda-Silva, F., Bianchetto-Aguilera, F. M., Finotti, G., Calzetti, F., Scapini, P., Lunardi, C., Cassatella, M. A., & Tamassia, N. (2016) · Scientific Reports · doi:10.1038/srep19674 · Cited by 96 · see citing works
Kallin, E. M., Rodríguez-Ubreva, J., Christensen, J., Cimmino, L., Aifantis, I., Helin, K., Ballestar, E., & Graf, T. (2012) · Molecular Cell · doi:10.1016/j.molcel.2012.08.007 · Cited by 92 · see citing works
Yamazaki, J., Jelı́nek, J., Lu, Y., Cesaroni, M., Madžo, J., Neumann, F., He, R. L., Taby, R. F., Vasanthakumar, A., Macrae, T. A., et al. (2015) · Cancer Research · doi:10.1158/0008-5472.can-14-0739 · Cited by 89 · see citing works
Myelodysplastic Syndromes (MDS) and autoimmune disorders (AD): Cause or consequence?
Braun, T., & Fenaux, P. (2013) · Best Practice & Research Clinical Haematology · doi:10.1016/j.beha.2013.09.003 · Cited by 85 · see citing works
Néemeth, Z. H., Leibovich, S. J., Deitch, E. A., Vizi, E. S., Szabó, C., & Haskó, G. (2003) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052944 · Cited by 75 · see citing works
Hydroxylation of 5-methylcytosine by TET2 maintains the active state of the mammalian HOXA cluster
Bocker, M., Tuorto, F., Raddatz, G., Musch, T., Yang, F., Xu, M., Lyko, F., & Breiling, A. (2012) · Nature Communications · doi:10.1038/ncomms1826 · Cited by 72 · see citing works
The inflammatory microenvironment in MDS
Yang, L., Qian, Y., Eksioglu, E. A., Epling‐Burnette, P. K., & Sheng, W. (2015) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-015-1846-x · Cited by 70 · see citing works
Su, X., Su, L., Meng, M., Qian, W., Xie, W., Chen, D., Zhai, Z., & Shu, H. (2005) · European Journal of Immunology · doi:10.1002/eji.200535415 · Cited by 60 · see citing works
Velegraki, M., Papakonstanti, E. A., Mavroudi, I., Psyllaki, M., Tsatsanis, C., Oulas, A., Iliopoulos, I., Katonis, P., & Papadaki, H. A. (2013) · Haematologica · doi:10.3324/haematol.2012.064642 · Cited by 56 · see citing works
Coomes, S. M., Pelly, V. S., Kannan, Y., Okoye, I., Czieso, S., Entwistle, L. J., Perez-Lloret, J., Nikolov, N., Potocnik, A. J., Bíró, J., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1004994 · Cited by 55 · see citing works
Myelodysplastic syndromes with monocytic component: hematologic and cytogenetic characterization.
Rigolin, G. M., Cuneo, A., Roberti, M. G., Bardi, A., & Castoldi, G. L. (1997) · PubMed · Cited by 43 · see citing works
Ariffin, J. K., Kapétanovic, R., Schaale, K., Gatica‐Andrades, M., Blumenthal, A., Schroder, K., & Sweet, M. J. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ab0815-339r · Cited by 17 · see citing works
Ring, B. A., Lacerda, A. F., Drummond, D. J., Wangen, C., Eaton, H. E., & Brunetti, C. R. (2013) · Journal of Virology · doi:10.1128/jvi.00637-13 · Cited by 13 · see citing works
Cull, A. H., & Rauh, M. J. (2017) · Journal of Leukocyte Biology · doi:10.1189/jlb.5ri0317-083r · Cited by 13 · see citing works
Zhou, Z., Wu, Y., Chen, L., Liu, L., Chen, H., Li, Z., & Chen, C. (2011) · In Vitro Cellular & Developmental Biology - Animal · doi:10.1007/s11626-011-9441-4 · Cited by 12 · see citing works
Singh, Z. N., Post, G. R., Kiwan, E. N., & Maddox, A. (2011) · Clinical Lymphoma Myeloma & Leukemia · doi:10.1016/j.clml.2011.03.019 · Cited by 12 · see citing works
Flagged first, then by citations
Cited by
Sorted by citations
Clonal hematopoiesis in human aging and disease
Jaiswal, S., & Ebert, B. L. (2019) · Science · doi:10.1126/science.aan4673 · Cited by 1,156 · see citing works
“Subsequent studies have confirmed the overexpression of Il6 and also found that Il1b, IL8 family chemokines, and other inflammatory mediators show increased expression in Tet2-deficient macrophages challenged with LDL or endotoxin (80, 87, 93).”
Interplay between inflammation and thrombosis in cardiovascular pathology
Stark, K., & Massberg, S. (2021) · Nature Reviews Cardiology · doi:10.1038/s41569-021-00552-1 · Cited by 1,033 · see citing works
Brain immunology and immunotherapy in brain tumours
Sampson, J. H., Gunn, M. D., Fecci, P. E., & Ashley, D. M. (2019) · Nature reviews. Cancer · doi:10.1038/s41568-019-0224-7 · Cited by 733 · see citing works
Sano, S., Oshima, K., Wang, Y., MacLauchlan, S., Katanasaka, Y., Sano, M., Zuriaga, M. A., Yoshiyama, M., Goukassian, D., Cooper, M. A., et al. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2017.12.037 · Cited by 699 · see citing works
Role of inflammation in the pathogenesis of atherosclerosis and therapeutic interventions
Raggi, P., Genest, J. J., Giles, J. T., Rayner, K. J., Dwivedi, G., Beanlands, R. S., & Gupta, M. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.07.014 · Cited by 434 · see citing works
Chronic infection drives Dnmt3a-loss-of-function clonal hematopoiesis via IFNγ signaling
Hormaechea-Agulla, D., Matatall, K. A., Le, D. T., Kain, B., Long, X., Kus, P., Jaksik, R., Challen, G. A., Kimmel, M., & King, K. Y. (2021) · Cell Stem Cell · doi:10.1016/j.stem.2021.03.002 · Cited by 329 · see citing works
Caiado, F., Pietras, E. M., & Manz, M. G. (2021) · Journal of Experimental Medicine · doi:10.1084/jem.20201541 · Cited by 289 · see citing works
Marnell, C. S., Bick, A. G., & Natarajan, P. (2021) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2021.07.004 · Cited by 296 · see citing works
Roles of JAK2 in Aging, Inflammation, Hematopoiesis and Malignant Transformation
Perner, F., Perner, C., Ernst, T., & Heidel, F. H. (2019) · Cells · doi:10.3390/cells8080854 · Cited by 247 · see citing works
An inflammatory environment containing TNFα favors Tet2-mutant clonal hematopoiesis
Abegunde, S. O., Buckstein, R., Wells, R. A., & Rauh, M. J. (2018) · Experimental Hematology · doi:10.1016/j.exphem.2017.11.002 · Cited by 230 · see citing works
Chronic immune response dysregulation in MDS pathogenesis
Barreyro, L., Chlon, T. M., & Starczynowski, D. T. (2018) · Blood · doi:10.1182/blood-2018-03-784116 · Cited by 226 · see citing works
Aging and the rise of somatic cancer-associated mutations in normal tissues
Risques, R. A., & Kennedy, S. R. (2018) · PLoS Genetics · doi:10.1371/journal.pgen.1007108 · Cited by 212 · see citing works
Fuster, J. J., Zuriaga, M. A., Zorita, V., MacLauchlan, S., Polackal, M. N., Viana-Huete, V., Ferrer-Pérez, A., Matesanz, N., Herrero-Cervera, A., Sano, S., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.108326 · Cited by 204 · see citing works
Macrophage–NLRP3 Activation Promotes Right Ventricle Failure in Pulmonary Arterial Hypertension
Al‐Qazazi, R., Lima, P., Prisco, S. Z., Potus, F., Dasgupta, A., Chen, K., Tian, L., Bentley, R. E. T., Mewburn, J., Martin, A. Y., et al. (2022) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.202110-2274oc · Cited by 203 · see citing works
Vitamin C and immune cell function in inflammation and cancer
Ang, A., Pullar, J. M., Currie, M. J., & Vissers, M. C. M. (2018) · Biochemical Society Transactions · doi:10.1042/bst20180169 · Cited by 191 · see citing works
Targeting epigenetics and non-coding RNAs in atherosclerosis: from mechanisms to therapeutics
Xu, S., Kamato, D., Little, P. J., Nakagawa, S., Pelisek, J., & Jin, Z. G. (2018) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2018.11.003 · Cited by 176 · see citing works
Somatic Mutations and Clonal Hematopoiesis
Fuster, J. J., & Walsh, K. (2018) · Circulation Research · doi:10.1161/circresaha.117.312115 · Cited by 163 · see citing works
Aging drives <i>Tet2</i> <i>+/−</i> clonal hematopoiesis via IL-1 signaling
Caiado, F., Kovtonyuk, L. V., Gonullu, N. G., Fullin, J., Boettcher, S., & Manz, M. G. (2023) · Blood · doi:10.1182/blood.2022016835 · Cited by 161 · see citing works
Clonal haematopoiesis and dysregulation of the immune system
Belizaire, R., Wong, W. J., Robinette, M. L., & Ebert, B. L. (2023) · Nature Reviews Immunology · doi:10.1038/s41577-023-00843-3 · Cited by 161 · see citing works
Muto, T., Walker, C. S., Choi, K., Hueneman, K., Smith, M. A., Gul, Z., Garcia-Manero, G., Ma, A., Zheng, Y., & Starczynowski, D. T. (2020) · Nature Immunology · doi:10.1038/s41590-020-0663-z · Cited by 155 · see citing works
Novel Insights Into the NLRP3 Inflammasome in Atherosclerosis
Jin, Y. H., & Fu, J. (2019) · Journal of the American Heart Association · doi:10.1161/jaha.119.012219 · Cited by 148 · see citing works
Comorbid and inflammatory characteristics of genetic subtypes of clonal hematopoiesis
Cook, E. K., Izukawa, T., Young, S., Rosen, G., Jamali, M., Zhang, L., Johnson, D., Bain, E., Hilland, J., Ferrone, C. K., et al. (2019) · Blood Advances · doi:10.1182/bloodadvances.2018024729 · Cited by 145 · see citing works
TET Enzymes and 5hmC in Adaptive and Innate Immune Systems
Lio, C. J., & Rao, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00210 · Cited by 139 · see citing works
Zhang, C. R. C., Nix, D., Gregory, M., Ciorba, M. A., Ostrander, E. L., Newberry, R. D., Spencer, D. H., & Challen, G. A. (2019) · Experimental Hematology · doi:10.1016/j.exphem.2019.11.008 · Cited by 137 · see citing works
Nam, A. S., Dusaj, N., Izzo, F., Murali, R., Myers, R. M., Mouhieddine, T. H., Sotelo, J., Benbarche, S., Waarts, M., Gaiti, F., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01179-9 · Cited by 140 · see citing works
Clonal Hematopoiesis: Mechanisms Driving Dominance of Stem Cell Clones
Challen, G., & Goodell, M. A. (2020) · Blood · doi:10.1182/blood.2020006510 · Cited by 131 · see citing works
The function and regulation of TET2 in innate immunity and inflammation
Cong, B., Zhang, Q., & Cao, X. (2020) · Protein & Cell · doi:10.1007/s13238-020-00796-6 · Cited by 131 · see citing works
Macrophage polarization and its impact on idiopathic pulmonary fibrosis
Ge, Z., Chen, Y. Q., Ma, L., Hu, F., & Xie, L. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1444964 · Cited by 138 · see citing works
Potus, F., Pauciulo, M. W., Cook, E. K., Zhu, N., Hsieh, A., Welch, C. L., Shen, Y., Tian, L., Lima, P., Mewburn, J. D., et al. (2020) · Circulation · doi:10.1161/circulationaha.119.044320 · Cited by 119 · see citing works
TET2 Function in Hematopoietic Malignancies, Immune Regulation, and DNA Repair
Feng, Y., Li, X., Cassady, K. M., Zou, Z., & Zhang, X. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00210 · Cited by 121 · see citing works
Clonal hematopoiesis and inflammation: Partners in leukemogenesis and comorbidity
Cook, E. K., Luo, M., & Rauh, M. J. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.01.011 · Cited by 121 · see citing works
Reprogramming the epigenome with vitamin C
Lee Chong, T., Ahearn, E. L., & Cimmino, L. (2019) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2019.00128 · Cited by 120 · see citing works
Crosstalk between metabolism and epigenetics during macrophage polarization
Zhang, K., & Jagannath, C. (2025) · Epigenetics & Chromatin · doi:10.1186/s13072-025-00575-9 · Cited by 128 · see citing works
TET Enzymes in the Immune System: From DNA Demethylation to Immunotherapy, Inflammation, and Cancer
López-Moyado, I. F., Ko, M., Hogan, P. G., & Rao, A. (2024) · Annual Review of Immunology · doi:10.1146/annurev-immunol-080223-044610 · Cited by 116 · see citing works
Cobo, I., Tanaka, T. N., Mangalhara, K. C., Lana, A. J., Yeang, C., Han, C. Z., Schlachetzki, J. C. M., Challcombe, J., Fixsen, B. R., Sakai, M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.06.022 · Cited by 115 · see citing works
Inflammatory Pathophysiology as a Contributor to Myeloproliferative Neoplasms
Fisher, D. A. C., Fowles, J. S., Zhou, A., & Oh, S. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.683401 · Cited by 115 · see citing works
Vlasschaert, C., McNaughton, A. J. M., Chong, M., Cook, E. K., Hopman, W. M., Kestenbaum, B. R., Robinson‐Cohen, C., Garland, J. S., Moran, S. M., Paré, G., et al. (2022) · Journal of the American Society of Nephrology · doi:10.1681/asn.2021060774 · Cited by 112 · see citing works
Clonal hematopoiesis, somatic mosaicism, and age-associated disease
Evans, M. A., & Walsh, K. (2022) · Physiological Reviews · doi:10.1152/physrev.00004.2022 · Cited by 105 · see citing works
TET2 Regulates the Neuroinflammatory Response in Microglia
Carrillo-Jimenez, A., Deniz, Ö., Niklison-Chirou, M. V., Ruiz, R., Bezerra-Salomão, K., Stratoulias, V., Amouroux, R., Yip, P. K., Vilalta, A., Cheray, M., et al. (2019) · Cell Reports · doi:10.1016/j.celrep.2019.09.013 · Cited by 104 · see citing works
Role of Methylation in Pro- and Anti-Cancer Immunity
Mehdi, A., & Rabbani, S. A. (2021) · Cancers · doi:10.3390/cancers13030545 · Cited by 102 · see citing works
Inflammatory Signaling Pathways in Preleukemic and Leukemic Stem Cells
Hemmati, S., Haque, T. Z., & Gritsman, K. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00265 · Cited by 101 · see citing works
Groarke, E. M., & Young, N. S. (2019) · Clinics in Geriatric Medicine · doi:10.1016/j.cger.2019.03.001 · Cited by 103 · see citing works
Epigenomic analysis of Parkinson’s disease neurons identifies Tet2 loss as neuroprotective
Marshall, L. L., Killinger, B. A., Ensink, E., Li, P., Li, K. X., Cui, W., Lubben, N., Weiland, M. J., Wang, X., Gordevičius, J., et al. (2020) · Nature Neuroscience · doi:10.1038/s41593-020-0690-y · Cited by 97 · see citing works
Afridi, R., Kim, J., Rahman, M. H., & Suk, K. (2020) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2020.00020 · Cited by 98 · see citing works
IRAK1 and IRAK4 as emerging therapeutic targets in hematologic malignancies
Bennett, J., & Starczynowski, D. T. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000693 · Cited by 100 · see citing works
SanMiguel, J. M., Eudy, E., Loberg, M. A., Young, K. A., Mistry, J. J., Mujica, K. D., Schwartz, L. S., Stearns, T. M., Challen, G. A., & Trowbridge, J. J. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-22-0086 · Cited by 93 · see citing works
The Impact of Inflammation-Induced Tumor Plasticity during Myeloid Transformation
Yeaton, A. H., Cayanan, G., Loghavi, S., Dolgalev, I., Leddin, E. M., Loo, C. E., Torabifard, H., Nicolet, D., Wang, J., Corrigan, K., et al. (2022) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-1146 · Cited by 97 · see citing works
Tet2 at the interface between cancer and immunity
Jiang, S. (2020) · Communications Biology · doi:10.1038/s42003-020-01391-5 · Cited by 89 · see citing works
The Role of Host Cell DNA Methylation in the Immune Response to Bacterial Infection
Qin, W., Scicluna, B. P., & van der Poll, T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.696280 · Cited by 85 · see citing works
Epigenetic reprogramming of immune cells in injury, repair, and resolution
Placek, K., Schultze, J. L., & Aschenbrenner, A. C. (2019) · Journal of Clinical Investigation · doi:10.1172/jci124619 · Cited by 83 · see citing works
Cobo, I., Tanaka, T. N., Glass, C. K., & Yeang, C. (2021) · Current Opinion in Hematology · doi:10.1097/moh.0000000000000688 · Cited by 84 · see citing works
RUNX1 Mutations in Inherited and Sporadic Leukemia
Bellissimo, D. C., & Speck, N. A. (2017) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2017.00111 · Cited by 79 · see citing works
Bellissimo, D. C., Chen, C.-H., Zhu, Q., Bagga, S., Lee, C.-T., He, B., Wertheim, G. B. W., Jordan, M. S., Tan, K., Worthen, G. S., et al. (2020) · Blood Advances · doi:10.1182/bloodadvances.2019000785 · Cited by 78 · see citing works
McClatchy, J., Strogantsev, R., Wolfe, E., Lin, H., Mohammadhosseini, M., Davis, B. A., Eden, C. O., Goldman, D., Fleming, W., Conley, P., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43697-y · Cited by 83 · see citing works
Loss of TET2 in human hematopoietic stem cells alters the development and function of neutrophils
Encabo, H. H., Aramburu, I. V., Albornoz, M. G., Piganeau, M., Wood, H. J., Song, A., Ferrelli, A., Sharma, A., Minutti, C. M., Domart, M., et al. (2023) · Cell stem cell · doi:10.1016/j.stem.2023.05.004 · Cited by 75 · see citing works
Ferrone, C. K., Blydt-Hansen, M., & Rauh, M. J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21020626 · Cited by 75 · see citing works
Pronk, E., & Raaijmakers, M. H. G. P. (2019) · Blood · doi:10.1182/blood-2018-10-844639 · Cited by 72 · see citing works
Márquez, E. J., Trowbridge, J. J., Kuchel, G. A., Banchereau, J., & Ucar, D. (2020) · Immunity & Ageing · doi:10.1186/s12979-020-00183-z · Cited by 71 · see citing works
Clonal hematopoiesis and non-hematologic disorders
Jaiswal, S. (2020) · Blood · doi:10.1182/blood.2019000989 · Cited by 182 · see citing works
Clonal hematopoiesis in cancer
Park, S. J., & Bejar, R. L. (2020) · Experimental Hematology · doi:10.1016/j.exphem.2020.02.001 · Cited by 63 · see citing works
Gondek, L. P., & Dezern, A. E. (2019) · The Lancet Haematology · doi:10.1016/s2352-3026(19)30211-x · Cited by 63 · see citing works
Clonal Hematopoiesis: Somatic Mutations in Blood Cells and Atherosclerosis
Natarajan, P., Jaiswal, S., & Kathiresan, S. (2018) · Circulation Genomic and Precision Medicine · doi:10.1161/circgen.118.001926 · Cited by 63 · see citing works
Teipel, R., Kroschinsky, F., Krämer, M., Kretschmann, T., Egger‐Heidrich, K., Kruger, T. E., Ruhnke, L., Herold, S., Stasik, S., Sockel, K., et al. (2022) · Blood Advances · doi:10.1182/bloodadvances.2021005747 · Cited by 61 · see citing works
Øbro, N. F., Grinfeld, J., Belmonte, M., Irvine, M., Shepherd, M. S., Rao, T. N., Karow, A., Riedel, L. M., Harris, O. B., Baxter, E. J., et al. (2020) · HemaSphere · doi:10.1097/hs9.0000000000000371 · Cited by 58 · see citing works
Macrophages Orchestrate Hematopoietic Programs and Regulate HSC Function During Inflammatory Stress
Seyfried, A. N., Maloney, J., & MacNamara, K. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01499 · Cited by 44 · see citing works
Clonal Hematopoiesis: From Mechanisms to Clinical Intervention
Köhnke, T., & Majeti, R. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0901 · Cited by 59 · see citing works
Immune Aging in Rheumatoid Arthritis
Weyand, C. M., & Goronzy, J. J. (2025) · Arthritis & Rheumatology · doi:10.1002/art.43105 · Cited by 56 · see citing works
Immunometabolism of Phagocytes and Relationships to Cardiac Repair
Zhang, S., Bories, G. F. P., Lantz, C. W., Emmons, R., Becker, A., Liu, E., Abecassis, M. M., Yvan‐Charvet, L., & Thorp, E. B. (2019) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2019.00042 · Cited by 52 · see citing works
Febbraio, M., Roy, C. B., & Levin, L. (2021) · International Dental Journal · doi:10.1016/j.identj.2021.07.006 · Cited by 51 · see citing works
Hematopoietic Stem Cells and the Immune System in Development and Aging
Shevyrev, D., Tereshchenko, V., Berezina, T. N., & Александрович, Р. С. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24065862 · Cited by 54 · see citing works
Flaming and fanning: The Spectrum of inflammatory influences in myelodysplastic syndromes
Banerjee, T., Calvi, L. M., Becker, M. W., & Liesveld, J. L. (2019) · Blood Reviews · doi:10.1016/j.blre.2019.04.004 · Cited by 51 · see citing works
Atrial Fibrillation and Clonal Hematopoiesis in TET2 and ASXL1
Saadatagah, S., Naderian, M., Uddin, M. M., Dikilitas, O., Niroula, A., Schuermans, A., Selvin, E., Hoogeveen, R. C., Matsushita, K., Nambi, V., et al. (2024) · JAMA Cardiology · doi:10.1001/jamacardio.2024.0459 · Cited by 51 · see citing works
Li, C., Ren, J., Zhang, M., Wang, H., Fang, Y., Wu, J., & Tang, Y. (2022) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-022-04536-3 · Cited by 50 · see citing works
Epigenetic regulation of innate immune dynamics during inflammation
Caldwell, B. A., & Li, L. (2024) · Journal of Leukocyte Biology · doi:10.1093/jleuko/qiae026 · Cited by 52 · see citing works
TET2 promotes anti‐tumor immunity by governing G‐MDSCs and CD8+ T‐cell numbers
Li, S., Feng, J., Wu, F., Cai, J., Zhang, X., Wang, H., Fetahu, I. S., Iwanicki, I. J., Ma, D., Hu, T., et al. (2020) · EMBO Reports · doi:10.15252/embr.201949425 · Cited by 45 · see citing works
Epigenetic Modifications in Tumor-Associated Macrophages: A New Perspective for an Old Foe
Niu, Y., Chen, J., & Qiao, Y. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.836223 · Cited by 48 · see citing works
Clonal hematopoiesis and its emerging effects on cellular therapies
Bonin, M. V., Jambor, H. K., Teipel, R., Stölzel, F., Thiede, C., Damm, F., Kroschinsky, F., Schetelig, J., Chavakis, T., & Bornhäuser, M. (2021) · Leukemia · doi:10.1038/s41375-021-01337-8 · Cited by 46 · see citing works
Roles and Mechanisms of DNA Methylation in Vascular Aging and Related Diseases
Xu, H., Li, S., & Liu, Y. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.699374 · Cited by 47 · see citing works
CHIP‐associated mutant ASXL1 in blood cells promotes solid tumor progression
Liu, X., Sato, N., Shimosato, Y., Wang, T., Denda, T., Chang, Y., Yabushita, T., Fujino, T., Asada, S., Tanaka, Y., et al. (2022) · Cancer Science · doi:10.1111/cas.15294 · Cited by 44 · see citing works
Clonal haematopoiesis, ageing and kidney disease
Vlasschaert, C., Lanktree, M. B., Rauh, M. J., Kelly, T. N., & Natarajan, P. (2023) · Nature Reviews Nephrology · doi:10.1038/s41581-023-00778-x · Cited by 41 · see citing works
Ma, Q., Dasgupta, C., Shen, G., Li, Y., & Zhang, L. (2021) · Journal of Neuroinflammation · doi:10.1186/s12974-020-02068-w · Cited by 41 · see citing works
Clonal hematopoiesis: Molecular and clinical implications
Kusne, Y. N., Xie, Z., & Patnaik, M. M. (2022) · Leukemia Research · doi:10.1016/j.leukres.2022.106787 · Cited by 41 · see citing works
The Role of Inflammation in the Initiation and Progression of Myeloid Neoplasms
Balandrán, J. C., Lasry, A., & Aifantis, I. (2023) · Blood Cancer Discovery · doi:10.1158/2643-3230.bcd-22-0176 · Cited by 41 · see citing works
Clonal Hematopoiesis of Indeterminate Potential From a Heart Failure Specialist's Point of View
Sikking, M. A., Stroeks, S. L. V. M., Waring, O. J., Henkens, M. T. H. M., Riksen, N. P., Hoischen, A., Heymans, S. R. B., & Verdonschot, J. A. J. (2023) · Journal of the American Heart Association · doi:10.1161/jaha.123.030603 · Cited by 41 · see citing works
Footprints of Sepsis Framed Within Community Acquired Pneumonia in the Blood Transcriptome
Hopp, L., Loeffler‐Wirth, H., Nersisyan, L., Arakelyan, A., & Binder, H. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.01620 · Cited by 39 · see citing works
TET3-overexpressing macrophages promote endometriosis
Lv, H., Liu, B., Dai, Y., Li, F., Bellone, S., Zhou, Y., Mamillapalli, R., Zhao, D., Venkatachalapathy, M., Hu, Y., et al. (2024) · Journal of Clinical Investigation · doi:10.1172/jci181839 · Cited by 40 · see citing works
Rix, B., Maduro, A. H., Bridge, K. S., & Grey, W. E. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.1009160 · Cited by 38 · see citing works
Disordered Immune Regulation and its Therapeutic Targeting in Myelodysplastic Syndromes
Ivy, K. S., & Ferrell, P. B. (2018) · Current Hematologic Malignancy Reports · doi:10.1007/s11899-018-0463-9 · Cited by 37 · see citing works
Molecular Targeted Therapy and Immunotherapy for Myelodysplastic Syndrome
Lee, P., Yim, R., Yung, Y., Chu, H.-T., Yip, P.-K., & Gill, H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms221910232 · Cited by 38 · see citing works
IL-1 in aging and pathologies of hematopoietic stem cells
Caiado, F., & Manz, M. G. (2024) · Blood · doi:10.1182/blood.2023023105 · Cited by 38 · see citing works
Tet2 Controls the Responses of β cells to Inflammation in Autoimmune Diabetes
Rui, J., Deng, S., Perdigoto, A. L., Ponath, G. D., Kursawe, R., Lawlor, N. T., Sumida, T. S., Levine-Ritterman, M., Stitzel, M. L., Pitt, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25367-z · Cited by 36 · see citing works
Circles of Life: linking metabolic and epigenetic cycles to immunity
Lio, C. J., & Huang, S. C. (2020) · Immunology · doi:10.1111/imm.13207 · Cited by 34 · see citing works
Immuno-Modulation of Hematopoietic Stem and Progenitor Cells in Inflammation
Sezaki, M., Hayashi, Y., Wang, Y., Johansson, A., Umemoto, T., & Takizawa, H. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585367 · Cited by 35 · see citing works
Nasillo, V., Riva, G., Paolini, A., Forghieri, F., Roncati, L., Lusenti, B., Maccaferri, M., Messerotti, A., Pioli, V., Gilioli, A., et al. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041906 · Cited by 36 · see citing works
Fattizzo, B., Giannotta, J. A., & Barcellini, W. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21155438 · Cited by 33 · see citing works
Gutierrez‐Rodrigues, F., Wells, K. V., Jones, A. I., Hironaka, D., Rankin, C., Gadina, M., Sikora, K. A., Alemu, L., Calado, R. T., Quinn, K. A., et al. (2023) · Annals of the Rheumatic Diseases · doi:10.1136/ard-2023-224933 · Cited by 32 · see citing works
The Role of Ten-Eleven Translocation Proteins in Inflammation
Gerecke, C., Rodrigues, C. E., Homann, T., & Kleuser, B. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.861351 · Cited by 36 · see citing works
Il-1r1 drives leukemogenesis induced by Tet2 loss
Burns, S. S., Kumar, R., Pasupuleti, S. K., So, K., Zhang, C., & Kapur, R. (2022) · Leukemia · doi:10.1038/s41375-022-01665-3 · Cited by 32 · see citing works
Clinico-Biological Features and Clonal Hematopoiesis in Patients with Severe COVID-19
Duployez, N., Demonchy, J., Berthon, C., Goutay, J., Caplan, M., Moreau, A.-S., Bignon, A. L., Marceau‐Renaut, A., Garrigue, D., Raczkiewicz, I., et al. (2020) · Cancers · doi:10.3390/cancers12071992 · Cited by 31 · see citing works
Newell, L. F., Williams, T. P., Liu, J., Yu, Y., Chen, Y., Booth, G. C., Knight, R. J., Goslee, K., Cook, R. J., Leonard, J. T., et al. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.04.014 · Cited by 31 · see citing works
- Authors
- Cull, A. H., Snetsinger, B., Buckstein, R., Wells, R. A., & Rauh, M. J.
- Affiliations
- Queen's University (CA)
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Rauh, Michael J.
- Venue
- Experimental Hematology
- Publisher
- Elsevier BV
- Published
- 2017-11
- Volume
- 55
- Pages
- 56-70.e13
- ISSN
- 0301-472X (ISSN-L)
- OpenAlex
- W2749902186
- Cited by
- 295
- References
- 62
- Citations by year
- 2026: 23 · 2025: 39 · 2024: 34 · 2023: 37 · 2022: 43 · 2021: 37 · 2020: 34 · 2019: 24 · 2018: 17 · 2017: 7
- FWCI
- 17.28
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Experimental Hematology (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- Queen's University
- Canada Foundation for Innovation
- Ontario Institute for Cancer Research
- Southeastern Ontario Academic Medical Organization
- Women's Giving Circle/University Hospitals Kingston Foundation
- Queen's University Terry Fox Foundation Training Program in Transdisciplinary Cancer Research
- Topics
- Health Sciences › Medicine › Hematology › Acute Myeloid Leukemia Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
- Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
- Keywords
- TET2, macrophages, inflammation resolution, 5-hydroxymethylcytosine, DNA demethylation, clonal hematopoiesis of indeterminate potential, myelodysplastic syndrome, chronic myelomonocytic leukemia, lipopolysaccharide response, NF-κB, interleukin-6, IL-1β, arginase-1, alternative macrophage activation, epigenetic dysregulation
- MeSH terms
- Animals, Arginase, Cell Differentiation, Cell Line, Cells, Cultured, DNA-Binding Proteins, Gene Expression Regulation, Humans, Inflammation, Lipopolysaccharides, Macrophages, Mice, Inbred C57BL, Mutation, Myelodysplastic Syndromes, Proto-Oncogene Proteins, Leukemia, Myelomonocytic, Chronic, Interleukin-6, Mice, Knockout, Dioxygenases, Interleukin-1beta
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
